Antoine Vasseur et al.
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis
Oncogene 2024, vol. 43, issue 16
doi: 10.1038/s41388-024-02986-6
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Antoine Vasseur et al.
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis
Oncogene 2024, vol. 43, issue 16
doi: 10.1038/s41388-024-02986-6